InvestorsHub Logo
Followers 67
Posts 3747
Boards Moderated 0
Alias Born 08/30/2009

Re: None

Thursday, 04/15/2021 4:20:55 PM

Thursday, April 15, 2021 4:20:55 PM

Post# of 232454
Courtesy of PUB3jw on YMB:
ALERT -- I have two long-standing college friends who are in Senior Mgmt. at both Pfizer and Merck. Today with Merck's announcement that they will be discontinuing the advancement/development of their COVID-19 vaccine MRK-7110, I thought I'd put a call into both of them to get their current thoughts on EUAs / FDA and Vaccines vs. Therapy alternatives. To my surprise, both friends were very aware of CYDY (more specifically Leronlimab) its EUA struggles, and some of the very positive recent results. In both conversations, I was able to confirm there are "current" conversations between their respective firms and CYDY. Additionally, both apologized that for "security reasons" they really couldn't comment on the nature of the discussions but assured me things appear very positive (emphasis added) for CYDY's future. I tried hard for both of them to "clarify" their statements, but both were getting uncomfortable with going any further with respect to the topic of Leronlimab. The one comment given to me (without any details) before the end of one of the calls was "hold on to your CYDY shares." You can interpret that in many ways. Thought I'd pass this along to this Board given there are so many folks here working so hard to get Leronlimab released to the larger, struggling therapeutics market.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News